SCHEMBL7165140

SCHEMBL7165140

CC1=NN(c2ccc(I)cc2)C(=O)C1N=Nc1c(C)[nH]n(-c2ccc(C(=O)O)cc2)c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.51
▸ MEN1 O00255 8/20 0.51
▸ ALOX5 P09917 1/20 0.48
▸ PTGS2 P35354 1/20 0.48
▸ MAPT P10636 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ MITF O75030 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ HSP90AA1 P07900 2/20 0.43
▸ POLB P06746 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159472 0.90 KMT2A (0.50) KMT2AMEN1ALOX5PTGS2MAPT
SCHEMBL5204074 0.84 MAPT (0.52) KMT2AMEN1MAPTSMN1; SMN2NPC1
SCHEMBL5204078 0.84 MAPT (0.52) KMT2AMEN1MAPTSMN1; SMN2NPC1
SCHEMBL7166971 0.83 KMT2A (0.49) KMT2AMEN1ALOX5PTGS2MAPT
SCHEMBL5202290 0.74 MEN1 (0.53) KMT2AMEN1MAPTSMN1; SMN2NPC1
SCHEMBL5202286 0.74 MEN1 (0.53) KMT2AMEN1MAPTSMN1; SMN2NPC1
SCHEMBL5202292 0.74 MEN1 (0.53) KMT2AMEN1MAPTSMN1; SMN2NPC1
SCHEMBL5206340 0.73 MAPT (0.50) KMT2AMEN1ALOX5MAPTSMN1; SMN2
SCHEMBL5206330 0.73 MAPT (0.50) KMT2AMEN1ALOX5MAPTSMN1; SMN2
SCHEMBL5202737 0.73 MAPT (0.50) KMT2AMEN1ALOX5MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552008-B1 Administering effective amount of a selected azo-pyrazole derivative for therapy of thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-04-22 — — US claimed
Send feedback